TY - JOUR
T1 - The natural history of preclinical diastolic dysfunction a population-based study
AU - Vogel, Mark W.
AU - Slusser, Joshua P.
AU - Hodge, David O.
AU - Chen, Horng H.
PY - 2012/3
Y1 - 2012/3
N2 - Background-Preclinical diastolic dysfunction (PDD) has been broadly defined as subjects with left ventricular diastolic dysfunction, without the diagnosis of congestive heart failure (HF) and with normal systolic function. Our objective was to determine the risk factors associated with the progression from PDD (stage B) HF to symptomatic (stage C) HF. Methods and Results-Using the resources of the Rochester Epidemiology Project, all residents of Olmsted County, MN, who underwent echocardiography between January 1, 2004, and December 31, 2005, and had grade 2-4 diastolic dysfunction and ejection fraction 50% were identified. Patients with a diagnosis of HF before or within 30 days of the echocardiogram were excluded. Patients were also excluded if they had a diagnosis of atrial fibrillation or severe mitral or aortic valve regurgitation at the time of the echocardiogram. A total of 388 patients met the inclusion criteria. The mean age of the cohort was 6712 years, with a female (57%) predominance. Prevalence of renal insufficiency (estimated glomerular filtration rate 60 mL/min per 1.73 m2) was 34%. The 3-year cumulative probabilities of development of (stage C) HF, development of atrial fibrillation, cardiac hospitalization, and mortality were 11.6%, 14.5%, 17.7%, and 10.1% respectively. In multivariable Cox proportional hazard regression analysis, we determined that age, renal dysfunction, and right ventricular systolic pressure were independently associated with the development of HF. Conclusions-This population-based study demonstrated that in PDD (stage B) HF, there was a moderate degree of progression to symptomatic (stage C) HF over 3 years, and renal dysfunction was associated with this progression independent of age, sex, hypertension, coronary disease, and ejection fraction.
AB - Background-Preclinical diastolic dysfunction (PDD) has been broadly defined as subjects with left ventricular diastolic dysfunction, without the diagnosis of congestive heart failure (HF) and with normal systolic function. Our objective was to determine the risk factors associated with the progression from PDD (stage B) HF to symptomatic (stage C) HF. Methods and Results-Using the resources of the Rochester Epidemiology Project, all residents of Olmsted County, MN, who underwent echocardiography between January 1, 2004, and December 31, 2005, and had grade 2-4 diastolic dysfunction and ejection fraction 50% were identified. Patients with a diagnosis of HF before or within 30 days of the echocardiogram were excluded. Patients were also excluded if they had a diagnosis of atrial fibrillation or severe mitral or aortic valve regurgitation at the time of the echocardiogram. A total of 388 patients met the inclusion criteria. The mean age of the cohort was 6712 years, with a female (57%) predominance. Prevalence of renal insufficiency (estimated glomerular filtration rate 60 mL/min per 1.73 m2) was 34%. The 3-year cumulative probabilities of development of (stage C) HF, development of atrial fibrillation, cardiac hospitalization, and mortality were 11.6%, 14.5%, 17.7%, and 10.1% respectively. In multivariable Cox proportional hazard regression analysis, we determined that age, renal dysfunction, and right ventricular systolic pressure were independently associated with the development of HF. Conclusions-This population-based study demonstrated that in PDD (stage B) HF, there was a moderate degree of progression to symptomatic (stage C) HF over 3 years, and renal dysfunction was associated with this progression independent of age, sex, hypertension, coronary disease, and ejection fraction.
KW - Diastolic dysfunction
KW - Heart failure
KW - Preserved ejection fraction
UR - http://www.scopus.com/inward/record.url?scp=84860815503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860815503&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.110.959668
DO - 10.1161/CIRCHEARTFAILURE.110.959668
M3 - Article
C2 - 22278404
AN - SCOPUS:84860815503
SN - 1941-3289
VL - 5
SP - 144
EP - 151
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 2
ER -